Mirum Pharmaceuticals, Inc.

NASDAQ:MIRM

40.4 (USD) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -163.415-135.665-83.988-103.27-52.553-17.348
Depreciation & Amortization 10.8293.6810.9750.6230.3240
Deferred Income Tax 9.777-6.580.5950.07200
Stock Based Compensation 35.02327.00723.08712.5546.070.051
Change In Working Capital -22.64-21.0516.9830.6117.1232.437
Accounts Receivables -43.974-20.7270000
Inventory -4.393-3.448-0.495000
Accounts Payables 30.7787.63922.6553.68310.0582.449
Other Working Capital -5.051-4.514-5.177-3.072-2.935-0.012
Other Non Cash Items 59.48212.471-90.410.335-0.32612.089
Operating Cash Flow -70.944-120.136-132.758-89.075-39.362-0.373
Investing Activities:
Investments In Property Plant And Equipment -20.109-0.278-19.024-0.225-0.281-7.5
Acquisitions Net -212.762-7.978-19-38.099127.50
Purchases Of Investments -27.329-132.322-198.029-74.562-1520
Sales Maturities Of Investments 153140.3157.6112.66124.50
Other Investing Activites 105.6717.97812738.099-127.5-11.25
Investing Cash Flow -107.27.748.54737.874-127.781-7.5
Financing Activities:
Debt Repayment -109.727-5.552-64.454-49.5750-0.05
Common Stock Issued 227.154114.6399.012131.87167.259.786
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 219.173109.087128.90898.99259.97789.754
Financing Cash Flow 336.6109.08773.466181.288127.17759.836
Other Information:
Effect Of Forex Changes On Cash -0.1330.012-0.0010.029-0.0270
Net Change In Cash 258.323-3.337-10.746130.116-39.99351.963
Cash At End Of Period 286.326128.003131.34142.08611.9751.963